Adamis Pharma up 15% ahead of FDA decision on higher dose naloxone

Adamis Pharmaceuticals (ADMP +14.7%) is up on a 6x surge in volume as investors expect the FDA nod for higher dose naloxone for the treatment of opioid overdose. The agency’s action date is today.

https://seekingalpha.com/news/3512642-adamis-pharma-15-percent-ahead-fda-decision-higher-dose-naloxone